THE founder of ventilator maker Shenzhen Mindray Bio-Medical Electronics Co, Li Xiting, took the top spot on Forbes’ Singapore Rich List for the first time this year, with his net worth soaring amid the Covid-19 pandemic.
Sun, 25 Apr 2021 11:42 UTC
Wuhan Institute of Virology in Wuhan, in China s central Hubei province, during a visit by members of the World Health Organization (WHO) team investigating the origins of the COVID-19 coronavirus. Scientists studying bat diseases at China s maximum-security laboratory in Wuhan were engaged in a massive project to investigate animal viruses alongside leading military officials - despite their denials of any such links.
Documents obtained by
The Mail on Sunday reveal that a nationwide scheme, directed by a leading state body, was launched nine years ago to discover new viruses and detect the dark matter of biology involved in spreading diseases.
How Wuhan scientists at Chinese lab helped army in top secret project to discover animal viruses
Updated: Apr 25 2021, 8:03 ET
SCIENTISTS studying bat diseases at a maximum-security lab in Wuhan helped military officials in a top secret project designed to investigate animal viruses, it has been reported.
The nationwide scheme, directed by a leading state body, is said to have launched nine years ago to find new bugs.
4
Shi Zhengli works with other researchers in a lab at the Wuhan Institute of Virology in Wuhan in central China s Hubei provinceCredit: AP
Documents seen by The Mail on Sunday detail the major project called the discovery of animal-delivered pathogens carried by wild animals .
Scientists at Wuhan lab were on massive project investigating animal viruses
Documents obtained by The Mail on Sunday have revealed a nationwide scheme
It was being directed by leading state body, which was launched nine years ago
Its aim was to find new viruses and detect dark matter of biology involved in spreading disease - alongside military officials, despite denials of any such links
February 18, 2021
published at 12:46 AMReuters
Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil.
Reuters
CHICAGO - A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday (Feb 17).
The study found the vaccine was still able to neutralise the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.